Medicina Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Medicina Ltd's estimated annual revenue is currently $5.2M per year.
- Medicina Ltd's estimated revenue per employee is $112,000
Employee Data
- Medicina Ltd has 46 Employees.
- Medicina Ltd grew their employee count by 0% last year.
Medicina Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Managing Director | Reveal Email/Phone |
2 | Product Manager | Reveal Email/Phone |
3 | Global Sales Marketing Director | Reveal Email/Phone |
4 | Territory Sales Manager | Reveal Email/Phone |
5 | Quality Assurance Technician | Reveal Email/Phone |
6 | Territory Sales Manager | Reveal Email/Phone |
Medicina Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Medicina Ltd?
Medicina is a privately owned group that has been designing, developing and selling products in the enteral feeding and stoma markets for over 20 years. Our product range includes nasogastric and gastrostomy kits, stoma care products, safety syringes, IV syringes and retractable safety syringes.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$5.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medicina Ltd News
Fang Bangjiang (derecha), jefe de los expertos en medicina tradicional ... de Shanghai Huayu Pharmaceutical Co Ltd, 18 de abril de 2022.
Global La Reducción De Peso Medicina Investigación de mercado es un ... Ltd, Hexal AG, Hexal AG, Lunan Pharmaceutical Group Corporation,...
China aprobó varios tratamientos, incluidos Paxlovid de Pfizer Inc y el medicamento basado en anticuerpos de Brii Biosciences Ltd para...